Lighting hydrogels via nanomaterials

Graduate student Patrick Lee and Dr. Akhilesh Gaharwar, associate professor, are developing a new class of hydrogels that can leverage light in a multitude of ways. Light is a particularly attractive source of energy as it can be confined to a predefined area as well as be finetuned by the time or intensity of light exposure. Their work was recently published in the journal Advanced Materials.

Light?responsive hydrogels are an emerging class of materials used for developing noninvasive, noncontact, precise and controllable medical devices in a wide range of biomedical applications, including photothermal therapy, photodynamic therapy, drug delivery and regenerative medicine.

Lee said light-responsive biomaterials are often used in biomedical applications; however, current light sources, such as ultraviolet light and visible light, cannot sufficiently penetrate the tissue to interact with the hydrogel. Instead, the team is researching near-infrared (NIR) light, which has a higher penetration depth.

The team is using a new class of two-dimensional nanomaterials known as molybdenum disulfide (MoS2), which has shown negligible toxicity to cells and superior NIR absorption. These nanosheets with high photothermal conversion efficiency can absorb and convert NIR light to heat, which can be developed to control thermoresponsive materials.

In the group's previous study published in Advanced Materials, certain polymers react with MoS2 nanosheets to form hydrogels. Building on this discovery, the team further utilizes MoS2 nanosheets and thermoresponsive polymers to control the hydrogel under NIR light by photothermal effect.

"This work leverages light to activate the dynamic polymer-nanomaterials interactions," Gaharwar said. "Upon NIR exposure, MoS2 acts as a crosslink epicenter by connecting with multiple polymeric chains via defect?driven click chemistry, which is unique."

NIR light allows internal formation of therapeutic hydrogels in the body for precise drug delivery. For cancer therapy, most of the drugs can be retained within the tumor, which will ease the side effects of chemotherapy. Moreover, NIR light can generate heat inside the tumors to ablate cancer cells, known as photothermal therapy. Therefore, a synergetic combination of photothermal therapy and chemotherapy has shown a higher efficacy in destroying cancer cells.

This study is funded by the New Innovator Award from the National Institutes of Health, as well as the Texas A&M President's Excellence Fund through X?grant and T3.